|
1
|
Finzi L, Kraemer A, Capron C, Noullet S,
Goere D, Penna C, Nordlinger B, Legagneux J, Emile JF and Malafosse
R: Improved retroviral suicide gene transfer in colon cancer cell
lines after cell synchronization with methotrexate. J Exp Clin
Cancer Res. 30:922011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jia W, Mei L, Wang Y, Liu L and Che G:
Double suicide genes selectively kill human umbilical vein
endothelial cells. Virol J. 8:742011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liu T, Ye L, He Y, Chen X, Peng J, Zhang
X, Yi H, Peng F and Leng A: Combination gene therapy using
VEGF-shRNA and fusion suicide gene yCDglyTK inhibits gastric
carcinoma growth. Exp Mol Pathol. 91:745–752. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Niu HX, Du T, Xu ZF, Zhang XK and Wang RG:
Role of wild type p53 and double suicide genes in interventional
therapy of liver cancer in rabbits. Acta Cir Bras. 27:522–528.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lee SW, Lee YL, Lee YJ, Park SY, Kim IS,
Choi TH, Ha JH, Ahn BC and Lee J: Enhanced antitumor effects by
combination gene therapy using MDR1 gene shRNA and HSV1-tk in a
xenograft mouse model. Cancer Lett. 291:83–89. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kim HA, Nam K, Lee M and Kim SW:
Hypoxia/hepatoma dual specific suicide gene expression plasmid
delivery using bio-reducible polymer for hepatocellular carcinoma
therapy. J Control Release. 171:1–10. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li S, Tokuyama T, Yamamoto J, Koide M,
Yokota N and Namba H: Potent bystander effect in suicide gene
therapy using neural stem cells transduced with herpes simplex
virus thymidine kinase gene. Oncology. 69:503–508. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yi BR, Choi KJ, Kim SU and Choi KC:
Therapeutic potential of stem cells expressing suicide genes that
selectively target human breast cancer cells: Evidence that they
exert tumoricidal effects via tumor tropism (Review). Int J Oncol.
41:798–804. 2012.
|
|
9
|
Jiang YX, Lu Y, Liu TJ, Yang J, Chen Y and
Fang YW: Using HSV-TK/GCV suicide gene therapy to inhibit lens
epithelial cell proliferation for treatment of posterior capsular
opacification. Mol Vis. 17:291–299. 2011.PubMed/NCBI
|
|
10
|
Yu BF, Wu J, Zhang Y, Sung HW, Xie J and
Li RK: Ultrasound-targeted HSVtk and Timp3 gene delivery for
synergistically enhanced antitumor effects in hepatoma. Cancer Gene
Ther. 20:290–297. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kuzmin D, Gogvadze E, Kholodenko R, Grzela
DP, Mityaev M, Vinogradova T, Kopantzev E, Malakhova G, Suntsova M,
Sokov D, Ivics Z and Buzdin A: Novel strong tissue specific
promoter for gene expression in human germ cells. BMC Biotechnol.
10:582010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Foekens JA, Peters HA, Grebenchtchikov N,
Look MP, Meijer-van Gelder ME, Geurts-Moespot A, van der Kwast TH,
Sweep CG and Klijn JG: High tumor levels of vascular endothelial
growth factor predict poor response to systemic therapy in advanced
breast cancer. Cancer Res. 61:5407–5414. 2001.PubMed/NCBI
|
|
13
|
Konecny GE, Meng YG, Untch M, Wang HJ,
Bauerfeind I, Epstein M, Stieber P, Vernes JM, Gutierrez J, Hong K,
Beryt M, Hepp H, Slamon DJ and Pegram MD: Association between
HER-2/neu and vascular endothelial growth factor expression
predicts clinical outcome in primary breast cancer patients. Clin
Cancer Res. 10:1706–1716. 2004. View Article : Google Scholar
|
|
14
|
Chen JF, Huang ZH, Huang YY, Song HJ and
Che XY: Construction of recombinant adenoviruses encoding TK
suicide gene driven by VEGF promoter using efficient AdEasier-1
system. Ai Zheng. 23:1093–1097. 2004.(In Chinese).
|
|
15
|
Rabenau HF, Rapp I and Steinmann J: Can
vaccinia virus be replaced by MVA virus for testing virucidal
activity of chemical disinfectants? BMC Infect Dis. 10: View Article : Google Scholar : 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhao W, Song Y, Xu B and Zhan Q:
Overexpression of centrosomal protein Nlp confers breast carcinoma
resistance to paclitaxel. Cancer Biol Ther. 13:156–163. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Puntel M, A K M GM, Farrokhi C, et al:
Safety profile, efficacy, and biodistribution of a bicistronic
high-capacity adenovirus vector encoding a combined
immunostimulation and cytotoxic gene therapy as a prelude to a
phase I clinical trial for glioblastoma. Toxicol Appl Pharmacol.
268:318–330. 2013. View Article : Google Scholar
|
|
18
|
Muhammad AK, Xiong W, Puntel M, Farrokhi
C, Kroeger KM, Salem A, Lacayo L, Pechnick RN, Kelson KR, Palmer D,
Ng P, Liu C, Lowenstein PR and Castro MG: Safety profile of gutless
adenovirus vectors delivered into the normal brain parenchyma:
implications for a glioma phase 1 clinical trial. Hum Gene Ther
Methods. 23:271–284. 2012. View Article : Google Scholar
|
|
19
|
Castro JE, Melo-Cardenas J, Urquiza M,
Barajas-Gamboa JS, Pakbaz RS and Kipps TJ: Gene immunotherapy of
chronic lymphocytic leukemia: a phase I study of intranodally
injected adenovirus expressing a chimeric CD154 molecule. Cancer
Res. 72:2937–2948. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Reetz J, Genz B, Meier C, Kowtharapu BS,
Timm F, Vollmar B, Herchenröder O, Abshagen K and Pützer BM:
Development of adenoviral delivery systems to target hepatic
stellate cells in vivo. PLoS One. 8:e670912013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang H, Sui A, Wang Z, Liu S and Yao R:
Adenovirus-mediated TRAIL expression and downregulation of Bcl-2
expression suppresses non-small cell lung cancer growth in
vitro and in vivo. Int J Mol Med. 30:358–364.
2012.PubMed/NCBI
|
|
22
|
Teramoto S, Johnson LG, Huang W, Leigh MW
and Boucher RC: Effect of adenoviral vector infection on cell
proliferation in cultured primary human airway epithelial cells.
Hum Gene Ther. 6:1045–1053. 1995. View Article : Google Scholar
|
|
23
|
Lee NO, Park JW, Lee JA, Shim JH, Kong SY,
Kim KT and Lee YS: Dual action of a selective cyclooxygenase-2
inhibitor on vascular endothelial growth factor expression in human
hepatocellular carcinoma cells: novel involvement of discoidin
domain receptor 2. J Cancer Res Clin Oncol. 138:73–84. 2012.
View Article : Google Scholar
|
|
24
|
Eisermann K, Broderick CJ, Bazarov A,
Moazam MM and Fraizer GC: Androgen up-regulates vascular
endothelial growth factor expression in prostate cancer cells via
an Sp1 binding site. Mol Cancer. 12:72013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lee KY, Lee JW, Nam HJ, Shim JH, Song Y
and Kang KW: PI3-kinase/p38 kinase-dependent E2F1 activation is
critical for Pin1 induction in tamoxifen-resistant breast cancer
cells. Mol Cells. 32:107–111. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cao X, Geradts J, Dewhirst MW and Lo HWU:
pregulation of VEGF-A and CD24 gene expression by the tGLI1
transcription factor contributes to the aggressive behavior of
breast cancer cells. Oncogene. 31:104–115. 2012. View Article : Google Scholar
|
|
27
|
Takayama K, Reynolds PN, Adachi Y,
Kaliberova L, Uchino J, Nakanishi Y and Curiel DT: Vascular
endothelial growth factor promoter-based conditionally replicative
adenoviruses for pan-carcinoma application. Cancer Gene Ther.
14:105–116. 2007. View Article : Google Scholar
|
|
28
|
Koshikawa N, Takenaga K, Tagawa M and
Sakiyama S: Therapeutic efficacy of the suicide gene driven by the
promoter of vascular endothelial growth factor gene against hypoxic
tumor cells. Cancer Res. 11:2936–2941. 2000.PubMed/NCBI
|
|
29
|
Kong H, Huang ZH, Li Z, Yu JL, Chen HJ and
Han XJ: Preliminary effect of VEGF promoter-driven recombinant
adenovirus containing double suicide genes on apoptosis of human
gastric carcinoma cells. Nan Fang Yi Ke Da Xue Xue Bao.
27:1152–1155. 2007.(In Chinese).
|
|
30
|
Li XH, Zhou P, Wang LH, Tian SM, Qian Y,
Chen LR and Zhang P: The targeted gene (KDRP-CD/TK) therapy of
breast cancer mediated by SonoVue and ultrasound irradiation in
vitro. Ultrasonics. 52:186–191. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Su GQ, Su G and Huang ZH:
Adenovirus-mediated tissue-targeted expression of the CDglyTk gene
for the treatment of breast cancer. Mol Med Rep. 6:321–329.
2012.PubMed/NCBI
|
|
32
|
Kang NH, Hwang KA, Yi BR, Lee HJ, Jeung
EB, Kim SU and Choi KC: Human amniotic fluid-derived stem cells
expressing cytosine deaminase and thymidine kinase inhibits the
growth of breast cancer cells in cellular and xenograft mouse
models. Cancer Gene Ther. 19:412–419. 2012. View Article : Google Scholar
|
